| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Original Research |
Nutrient Requirements and Functions Laboratory, Beltsville Human Nutrition Research Center, USDA, ARS, Beltsville, MD (R.A.A.)
LBSO, Oxidative Stress Laboratory, Joseph Fourier University, Grenoble (A.M.R.)
Laboratoires Labcatal, Montrouge Cedex (J.M.M.), FRANCE
Service d’Explorations fonctionnelle and Endocrinologie Metabolisme Hopital, Sfax (N.Z.)
Service de Medecine interne, Hopital de Monastir (S.M.)
Laboratoire de Biophysique, Faculté de Médecine (A.K.), Monastir, TUNISIA
Address reprint requests to: Richard A. Anderson, PhD Nutrient Requirements and Functions Laboratory, Bldg 307, Rm 224, Beltsville Human Nutrition Research Center, USDA, ARS, Beltsville, MD 20705. E-mail: anderson{at}307.bhnrc.usda.gov
Objective: To determine the effects of combined zinc (Zn) and chromium (Cr) supplementation on oxidative stress and glucose homeostasis of people with type 2 diabetes.
Design: Tunisian adult subjects with HbA1C >7.5% were supplemented for 6 months with 30 mg/d of Zn as Zn gluconate or 400 µg/d of Cr as Cr pidolate or combined Zn/Cr supplementation or placebo. The effects of supplementation on plasma zinc (Zn), copper (Cu), selenium (Se), urinary Zn, Cr, plasma thiobarbituric acid reactive substances (TBARS), Cu-Zn superoxide dismutase (SOD) and Se glutathione peroxidase (GPx) in red blood cells, blood lipids and lipoproteins, HbA1C and fasting glucose were measured at the beginning of the study and after six months.
Results: At the beginning of the study, more than 30% of the subjects may have been Zn deficient with plasma Zn values less than 10.7 µmol/L, whereas levels of plasma Cu, Se and antioxidant RBC enzyme activities were in the normal ranges. Following supplementation, there were significant decreases of plasma TBARS in the Cr (13.6%), Zn (13.6%) and Zn/Cr (18.2%) groups with no significant changes in the placebo group. The value for the TBARS of the control healthy Tunisian subjects was 2.08 ± 0.04 µmol/L and that of the Tunisian subjects with diabetes was 3.32 ± 0.05 µmol/L. This difference of 1.24 µmol/L between the control group and the subjects with diabetes was reduced from 36% to 50% in the three supplemented groups. Supplementation did not modify significantly HbA1C nor glucose homeostasis. No adverse effects of Zn supplementation were observed on Cu status, HDL cholesterol nor interactions in Zn or Cr.
Conclusions: These data suggest the potential beneficial antioxidant effects of the individual and combined supplementation of Zn and Cr in people with type 2 DM. These results are particularly important in light of the deleterious consequences of oxidative stress in people with diabetes.
Key words: zinc, chromium, antioxidants, TBARS, lipid peroxidation, glucose homeostasis, trace elements, diabetes
This article has been cited by other articles:
|
|
 |
|
  M. Via, C. Scurlock, J. Raikhelkar, G. D. Luozzo, and J. I. Mechanick Chromium Infusion Reverses Extreme Insulin Resistance in a Cardiothoracic ICU Patient Nutr Clin Pract, June 1, 2008; 23(3): 325 - 328. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Abe, Y. Tanaka, N. Fujise, T. Nakamura, H. Masunaga, T. Nagasawa, and M. Yagi An Antioxidative Nutrient-Rich Enteral Diet Attenuates Lethal Activity and Oxidative Stress Induced by Lipopolysaccharide in Mice JPEN J Parenter Enteral Nutr, May 1, 2007; 31(3): 181 - 187. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Soinio, J. Marniemi, M. Laakso, K. Pyorala, S. Lehto, and T. Ronnemaa Serum Zinc Level and Coronary Heart Disease Events in Patients With Type 2 Diabetes Diabetes Care, March 1, 2007; 30(3): 523 - 528. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Chimienti, S. Devergnas, F. Pattou, F. Schuit, R. Garcia-Cuenca, B. Vandewalle, J. Kerr-Conte, L. Van Lommel, D. Grunwald, A. Favier, et al. In vivo expression and functional characterization of the zinc transporter ZnT8 in glucose-induced insulin secretion J. Cell Sci., October 15, 2006; 119(20): 4199 - 4206. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Sahin and O. Kucuk Zinc Supplementation Alleviates Heat Stress in Laying Japanese Quail J. Nutr., September 1, 2003; 133(9): 2808 - 2811. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A.-M. Roussel, A. Kerkeni, N. Zouari, S. Mahjoub, J.-M. Matheau, and R. A. Anderson Antioxidant Effects of Zinc Supplementation in Tunisians with Type 2 Diabetes Mellitus J. Am. Coll. Nutr., August 1, 2003; 22(4): 316 - 321. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. J Ryan, N. S Wanko, A. R Redman, and C. B Cook Chromium as Adjunctive Treatment for Type 2 Diabetes Ann. Pharmacother., June 1, 2003; 37(6): 876 - 885. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Y. Yeh, D. M. Eisenberg, T. J. Kaptchuk, and R. S. Phillips Systematic Review of Herbs and Dietary Supplements for Glycemic Control in Diabetes Diabetes Care, April 1, 2003; 26(4): 1277 - 1294. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. T. Cefalu, Z. Q. Wang, X. H. Zhang, L. C. Baldor, and J. C. Russell Oral Chromium Picolinate Improves Carbohydrate and Lipid Metabolism and Enhances Skeletal Muscle Glut-4 Translocation in Obese, Hyperinsulinemic (JCR-LA Corpulent) Rats J. Nutr., June 1, 2002; 132(6): 1107 - 1114. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
